会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 94. 发明申请
    • HYBRID SYSTEMS FOR LOCOMOTIVES
    • 混合动力系统
    • US20160001799A1
    • 2016-01-07
    • US14853905
    • 2015-09-14
    • David Cook
    • David Cook
    • B61H11/00B61C17/06B61C3/00
    • B61H11/00B61C3/00B61C17/06B61C17/12F01N3/023F01N9/002F01N2590/08F01N2590/11F01N2900/08Y02T30/18
    • A locomotive consist includes a first locomotive unit that receives a power command from a throttle signal or a dynamic brake signal from MU trainlines, a second locomotive unit with an energy storage system electrically connected to one or more second unit traction motors, and a hybrid control system on the first locomotive unit. The hybrid control system intercepts the throttle signal or the dynamic brake signal from the MU trainlines, calculates first and second alternate power commands for the first and second locomotive units, respectively, that when added together equal the power command received on the MU trainlines, communicates the first power command to the first locomotive prime engine or dynamic braking system, and communicates the second power command to the second locomotive unit.
    • 一种机车组件包括:第一机车单元,其接收来自MU训练线路的油门信号或动态制动信号的功率指令;第二机车单元,其具有电连接到一个或多个第二单元牵引马达的能量存储系统;以及混合控制 系统在第一机车单元上。 混合控制系统截取来自MU训练线路的节气门信号或动态制动信号,分别计算第一和第二机车单元的第一和第二替代功率命令,当加在一起等于在MU训练线路上接收的功率命令时,通信 对第一机车主引擎或动态制动系统的第一电力指令,并将第二电力指令传送到第二机车单元。
    • 100. 发明申请
    • Therapeutic agent elution control process
    • 治疗剂洗脱控制过程
    • US20080026034A1
    • 2008-01-31
    • US11493324
    • 2006-07-26
    • David CookRobert FaloticoLily KuoJonathon Z. Zhao
    • David CookRobert FaloticoLily KuoJonathon Z. Zhao
    • A61F2/02A61K31/4745
    • A61L31/10A61F2/07A61F2/91A61F2/95A61F2/954A61F2002/065A61F2002/075A61L31/16A61L2300/416A61L2300/606
    • Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including vulnerable plaque. Implantable coated medical devices may be processed through annealing to better control the elution characteristics of the therapeutic agents. Furthermore, annealing leads to better therapeutic agent stability and a larger device shelf-life.
    • 可以涂覆医疗装置,特别是可植入医疗装置,以最小化或基本上消除生物体对将生物体引入医疗装置的反应。 医疗装置可以涂覆任何数量的生物相容性材料。 治疗药物,药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 这些治疗剂或化合物还可以进一步减少生物体对将生物体引入医疗装置的反应。 此外,这些治疗药物,药剂和/或化合物可用于促进愈合,包括预防血栓形成。 药物,药剂和/或化合物也可用于治疗特定疾病,包括易损斑块。 可以通过退火处理可植入的涂覆的医疗装置,以更好地控制治疗剂的洗脱特性。 此外,退火导致更好的治疗剂稳定性和更大的器件保质期。